IR
63
-3
MCO
71
-7
PAYX
48
-6
CRM
60
-7
COP
57
-2
TMO
42
-6
ADSK
66
-4
GM
74
5
DVN
14
-6
SHW
62
-6
EQT
51
-3
PYPL
52
-2
CINF
53
3
CA
22
-3
SWK
50
-5
SYY
49
9
AZO
50
-5
CNX
73
-3
FSLR
44
-2
AA
56
15
IR
63
-3
MCO
71
-7
PAYX
48
-6
CRM
60
-7
COP
57
-2
TMO
42
-6
ADSK
66
-4
GM
74
5
DVN
14
-6
SHW
62
-6
EQT
51
-3
PYPL
52
-2
CINF
53
3
CA
22
-3
SWK
50
-5
SYY
49
9
AZO
50
-5
CNX
73
-3
FSLR
44
-2
AA
56
15
Financhill
Back

Putnam Premier Income Trust Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
37

PPT
Putnam Premier Income Trust

Last Price:
3.51
Seasonality Move:
1.1%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
37
Putnam Premier Income Trust (PPT) is a Sell

Is Putnam Premier Income Trust a Buy, Sell or Hold?

  • The current Putnam Premier Income Trust [PPT] share price is $3.50. The Score for PPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • PPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PPT Stock Price Chart

What is Putnam Premier Income Trust's stock price today?

  • The Putnam Premier Income Trust share price today is $3.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PPT is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 30.19 Sell
Chaikin Money Flow: 33910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.56 - 3.66) Sell
Bollinger Bands (100): (3.59 - 3.69) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.56 Sell
20-day SMA: 3.59 Sell
50-day SMA: 3.66 Sell
200-day SMA: 3.58 Sell
8-day EMA: 3.55 Sell
20-day EMA: 3.59 Sell
50-day EMA: 3.62 Sell
200-day EMA: 3.6 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Putnam Premier Income Trust Earnings Growth & PPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Putnam Premier Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):